Biora Therapeutics, Inc.: basic weighted-average shares

What this measure means

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Exact concept: us-gaap:WeightedAverageNumberOfSharesOutstandingBasic. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2021-01-01 to 2023-12-31. The SEC response was captured on 2026-09-21.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Reading these values

This selected numerical history matches Diluted weighted-average shares for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.

Selected filing history

Related financial histories

• Biora Therapeutics, Inc.: total assets
• Biora Therapeutics, Inc.: total liabilities
• Biora Therapeutics, Inc.: stockholders equity
• Biora Therapeutics, Inc.: cash and cash equivalents
• Biora Therapeutics, Inc.: net income or loss
• Biora Therapeutics, Inc.: operating cash flow
• Biora Therapeutics, Inc.: capital expenditure payments
• Biora Therapeutics, Inc.: revenue
• Biora Therapeutics, Inc.: contract revenue excluding tax
• Biora Therapeutics, Inc.: financing cash flow
• Biora Therapeutics, Inc.: investing cash flow
• Biora Therapeutics, Inc.: retained earnings or deficit
• Biora Therapeutics, Inc.: diluted weighted-average shares
• Biora Therapeutics, Inc.: basic earnings per share
• Biora Therapeutics, Inc.: diluted earnings per share
• Biora Therapeutics, Inc.: income tax expense or benefit
• Biora Therapeutics, Inc.: net property, plant and equipment
• Biora Therapeutics, Inc.: share-based compensation expense
• Biora Therapeutics, Inc.: operating income or loss
• Biora Therapeutics, Inc.: current assets
• Biora Therapeutics, Inc.: interest expense
• Biora Therapeutics, Inc.: current liabilities
• Biora Therapeutics, Inc.: current accounts payable
• Biora Therapeutics, Inc.: goodwill carrying amount
• Biora Therapeutics, Inc.: net current accounts receivable
• Biora Therapeutics, Inc.: operating expenses
• Biora Therapeutics, Inc.: gross profit
• Biora Therapeutics, Inc.: selling, general and administrative expense
• Biora Therapeutics, Inc.: research and development expense
• Biora Therapeutics, Inc.: common shares outstanding
• Biora Therapeutics, Inc.: cash including restricted cash
• Biora Therapeutics, Inc.: operating lease right-of-use asset
• Biora Therapeutics, Inc.: gross property, plant and equipment
• Biora Therapeutics, Inc.: accumulated depreciation on property, plant and equipment
• Biora Therapeutics, Inc.: other noncurrent assets
• Biora Therapeutics, Inc.: other noncurrent liabilities
• Biora Therapeutics, Inc.: prepaid expenses and other current assets
• Biora Therapeutics, Inc.: current contract liabilities
• Biora Therapeutics, Inc.: pre-tax income or loss from continuing operations
• Biora Therapeutics, Inc.: profit or loss including noncontrolling interests
• Biora Therapeutics, Inc.: general and administrative expense
• Biora Therapeutics, Inc.: depreciation expense
• Biora Therapeutics, Inc.: amortization of intangible assets
• Biora Therapeutics, Inc.: nonoperating income or expense
• Biora Therapeutics, Inc.: current income tax expense or benefit
• Biora Therapeutics, Inc.: deferred income tax expense or benefit
• Biora Therapeutics, Inc.: interest paid, net
• Biora Therapeutics, Inc.: income taxes paid, net
• Biora Therapeutics, Inc.: proceeds from issuing common stock
• Biora Therapeutics, Inc.: change in accounts payable

Inspect the source

Entity

Biora Therapeutics, Inc. / CIK 0001580063

Captured

2026-09-21T17:20:55.766Z

SEC response SHA-256

fec25fcdb7fb06d85feffd9ee17ee9160f293afb10e93fa3d30b4aea9eeb0ba2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001580063.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))